Abstract 069: Alteplase Or Tenecteplase Prior To Endovascular Therapy – Does It Matter?
Introduction Thrombolysis with recombinant tissue plasminogen activator remains vital to acute ischemic stroke (AIS) therapy. Several centers in the United States are adopting Tenecteplase (TNK) over Alteplase (ALT) due to its ease of administration, fibrin specificity, longer half‐life, and non‐inf...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-11-01
|
| Series: | Stroke: Vascular and Interventional Neurology |
| Online Access: | https://www.ahajournals.org/doi/10.1161/SVIN.03.suppl_2.069 |